NFKB1 and inflammatory bowel disease: They demonstrated that modulating Akkermansia impacts thiamine metabolism and inhibits macrophage activation, thereby regulating NF-κB/Nrf2/COX-2-mediated inflammation and oxidative stress in inflammatory bowel disease.